At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Small molecules
- Mechanism of Action DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 15 Mar 1995 Discontinued-Preclinical for Herpes simplex virus infections in United Kingdom (Unknown route)